We found that the expression of TGFβ2 was significantly elevated relative to normal controls in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD) and thyroid carcinoma (THCA). The gene discussed is TGFB2; the disease is thyroid gland carcinoma.